{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:04:59Z","timestamp":1785470699927,"version":"3.56.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02006-6","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T03:01:47Z","timestamp":1720234907000},"page":"2473-2479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Genetic biomarkers of cognitive impairment and dementia of potential interest in CKD patients"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1996","authenticated-orcid":false,"given":"Carmine","family":"Zoccali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"key":"2006_CR1","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D et al (2021) Chronic kidney disease. Lancet 398:786\u2013802. https:\/\/doi.org\/10.1016\/S0140-6736(21)00519-5","journal-title":"Lancet"},{"key":"2006_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","volume":"379","author":"AS Levey","year":"2012","unstructured":"Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379:165\u2013180. https:\/\/doi.org\/10.1016\/S0140-6736(11)60178-5","journal-title":"Lancet"},{"key":"2006_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/J.1525-139X.2007.00384.X","volume":"21","author":"M Madero","year":"2008","unstructured":"Madero M, Gul A, Sarnak MJ (2008) Cognitive function in chronic kidney disease. Semin Dial 21:29\u201337. https:\/\/doi.org\/10.1111\/J.1525-139X.2007.00384.X","journal-title":"Semin Dial"},{"key":"2006_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/jgs.15683","volume":"67","author":"MJR Aliberti","year":"2019","unstructured":"Aliberti MJR, Cenzer IS, Smith AK et al (2019) Assessing risk for adverse outcomes in older adults: the need to include both physical frailty and cognition. J Am Geriatr Soc 67:477\u2013483. https:\/\/doi.org\/10.1111\/jgs.15683","journal-title":"J Am Geriatr Soc"},{"key":"2006_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12888-020-02618-9","volume":"20","author":"M-C Wang","year":"2020","unstructured":"Wang M-C, Li T-C, Li C-I et al (2020) Cognitive function and its transitions in predicting all-cause mortality among urban community-dwelling older adults. BMC Psychiatry 20:203. https:\/\/doi.org\/10.1186\/s12888-020-02618-9","journal-title":"BMC Psychiatry"},{"key":"2006_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S1474-4422(14)70026-2","volume":"13","author":"K Toyoda","year":"2014","unstructured":"Toyoda K, Ninomiya T (2014) Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol 13:823\u2013833. https:\/\/doi.org\/10.1016\/S1474-4422(14)70026-2","journal-title":"Lancet Neurol"},{"key":"2006_CR7","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/JGS.13594","volume":"63","author":"DH Kim","year":"2015","unstructured":"Kim DH, Grodstein F, Newman AB et al (2015) Microvascular and macrovascular abnormalities and cognitive and physical function in older adults: cardiovascular health study. J Am Geriatr Soc 63:1886\u20131893. https:\/\/doi.org\/10.1111\/JGS.13594","journal-title":"J Am Geriatr Soc"},{"key":"2006_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1681\/ASN.2012050536","volume":"24","author":"J-M Bugnicourt","year":"2013","unstructured":"Bugnicourt J-M, Godefroy O, Chillon J-M et al (2013) Cognitive disorders and dementia in CKD. J Am Soc Nephrol 24:353\u2013363. https:\/\/doi.org\/10.1681\/ASN.2012050536","journal-title":"J Am Soc Nephrol"},{"key":"2006_CR9","doi-asserted-by":"publisher","first-page":"E35555","DOI":"10.1097\/MD.0000000000035555","volume":"102","author":"J Li","year":"2023","unstructured":"Li J, Li Y, Niu J et al (2023) Exploration of the shared genetic biomarkers in Alzheimer\u2019s disease and chronic kidney disease using integrated bioinformatics analysis. Medicine 102:E35555. https:\/\/doi.org\/10.1097\/MD.0000000000035555","journal-title":"Medicine"},{"key":"2006_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/01616412.2022.2158640","volume":"45","author":"X Liu","year":"2023","unstructured":"Liu X, Ou YN, Ma YH et al (2023) Renal function and neurodegenerative diseases\u202f: a two-sample Mendelian randomization study. Neurol Res 45:456\u2013464. https:\/\/doi.org\/10.1080\/01616412.2022.2158640","journal-title":"Neurol Res"},{"key":"2006_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12967-022-03799-5\/FIGURES\/5","volume":"21","author":"E Gagnon","year":"2023","unstructured":"Gagnon E, Mitchell PL, Manikpurage HD et al (2023) Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study. J Transl Med 21:1\u201314. https:\/\/doi.org\/10.1186\/S12967-022-03799-5\/FIGURES\/5","journal-title":"J Transl Med"},{"key":"2006_CR12","doi-asserted-by":"publisher","first-page":"E2581","DOI":"10.1212\/WNL.0000000000009642","volume":"94","author":"S Marini","year":"2020","unstructured":"Marini S, Georgakis MK, Chung J et al (2020) Genetic overlap and causal inferences between kidney function and cerebrovascular disease. Neurology 94:E2581\u2013E2591. https:\/\/doi.org\/10.1212\/WNL.0000000000009642","journal-title":"Neurology"},{"key":"2006_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106\u2013118. https:\/\/doi.org\/10.1038\/nrneurol.2012.263","journal-title":"Nat Rev Neurol"},{"key":"2006_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-2350-10-108\/TABLES\/4","volume":"10","author":"AY Chu","year":"2009","unstructured":"Chu AY, Parekh RS, Astor BC et al (2009) Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a third national health and nutrition examination survey (NHANES III) genetic study. BMC Med Genet 10:108. https:\/\/doi.org\/10.1186\/1471-2350-10-108\/TABLES\/4","journal-title":"BMC Med Genet"},{"key":"2006_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/NG0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ et al (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7:180\u2013184. https:\/\/doi.org\/10.1038\/NG0694-180","journal-title":"Nat Genet"},{"key":"2006_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JAD-2002-4304","volume":"4","author":"GW Rebeck","year":"2002","unstructured":"Rebeck GW, Kindy M, LaDu MJ (2002) Apolipoprotein E and Alzheimer\u2019s disease: the protective effects of ApoE2 and E3. J Alzheimers Dis 4:145\u2013154. https:\/\/doi.org\/10.3233\/JAD-2002-4304","journal-title":"J Alzheimers Dis"},{"key":"2006_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/JAMA.265.1.78","volume":"265","author":"RW Mahley","year":"1991","unstructured":"Mahley RW, Weisgraber KH, Innerarity TL, Rall SC (1991) Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism. JAMA 265:78\u201383. https:\/\/doi.org\/10.1001\/JAMA.265.1.78","journal-title":"JAMA"},{"key":"2006_CR18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/SCIENCE.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261:921\u2013923. https:\/\/doi.org\/10.1126\/SCIENCE.8346443","journal-title":"Science"},{"key":"2006_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.molmed.2015.12.002","volume":"22","author":"T Ernandez","year":"2016","unstructured":"Ernandez T, Mayadas TN (2016) The changing landscape of renal inflammation. Trends Mol Med 22:151\u2013163. https:\/\/doi.org\/10.1016\/j.molmed.2015.12.002","journal-title":"Trends Mol Med"},{"key":"2006_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/J.IMBIO.2011.07.017","volume":"217","author":"H Crehan","year":"2012","unstructured":"Crehan H, Holton P, Wray S et al (2012) Complement receptor 1 (CR1) and Alzheimer\u2019s disease. Immunobiology 217:244\u2013250. https:\/\/doi.org\/10.1016\/J.IMBIO.2011.07.017","journal-title":"Immunobiology"},{"key":"2006_CR21","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"J-C Lambert","year":"2009","unstructured":"Lambert J-C, Heath S, Even G et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41:1094\u20131099. https:\/\/doi.org\/10.1038\/ng.439","journal-title":"Nat Genet"},{"key":"2006_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1167886","author":"G Milinkeviciute","year":"2023","unstructured":"Milinkeviciute G, Green KN (2023) Clusterin\/apolipoprotein J, its isoforms and Alzheimer\u2019s disease. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2023.1167886","journal-title":"Front Aging Neurosci"},{"key":"2006_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/ki.1994.108","volume":"45","author":"JR Saunders","year":"1994","unstructured":"Saunders JR, Aminian A, Mcrae JL et al (1994) Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney. Kidney Int 45:817\u2013827","journal-title":"Kidney Int"},{"key":"2006_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/NG.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41:1088\u20131093. https:\/\/doi.org\/10.1038\/NG.440","journal-title":"Nat Genet"},{"key":"2006_CR25","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.4103\/1673-5374.301013","volume":"16","author":"H-J Moon","year":"2021","unstructured":"Moon H-J, Herring S, Zhao L (2021) Clusterin: a multifaceted protein in the brain. Neural Regen Res 16:1438. https:\/\/doi.org\/10.4103\/1673-5374.301013","journal-title":"Neural Regen Res"},{"key":"2006_CR26","doi-asserted-by":"crossref","unstructured":"Woody SK, Zhao L (2016) Clusterin (APOJ) in Alzheimer\u2019s Disease: an old molecule with a new role. In: update on dementia. https:\/\/www.intechopen.com\/chapters\/52368","DOI":"10.5772\/64233"},{"key":"2006_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/J.1600-0854.2007.00549.X","volume":"8","author":"P Nizard","year":"2007","unstructured":"Nizard P, Tetley S, Le Dr\u00e9an Y et al (2007) Stress-induced retrotranslocation of clusterin\/ApoJ into the cytosol. Traffic 8:554\u2013565. https:\/\/doi.org\/10.1111\/J.1600-0854.2007.00549.X","journal-title":"Traffic"},{"key":"2006_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00164","author":"EM Foster","year":"2019","unstructured":"Foster EM, Dangla-Valls A, Lovestone S et al (2019) Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2019.00164","journal-title":"Front Neurosci"},{"key":"2006_CR29","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1038\/s41467-021-25060-1","volume":"12","author":"P Yuste-Checa","year":"2021","unstructured":"Yuste-Checa P, Trinkaus VA, Riera-Tur I et al (2021) The extracellular chaperone clusterin enhances tau aggregate seeding in a cellular model. Nat Commun 12:4863. https:\/\/doi.org\/10.1038\/s41467-021-25060-1","journal-title":"Nat Commun"},{"key":"2006_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2174\/15672050113106660162","volume":"10","author":"G Mullan","year":"2013","unstructured":"Mullan G, McEneny J, Fuchs M et al (2013) Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer\u2019s disease. Curr Alzheimer Res 10:973\u2013978. https:\/\/doi.org\/10.2174\/15672050113106660162","journal-title":"Curr Alzheimer Res"},{"key":"2006_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s13311-022-01185-z","volume":"19","author":"R Duara","year":"2022","unstructured":"Duara R, Barker W (2022) Heterogeneity in Alzheimer\u2019s disease diagnosis and progression rates: implications for therapeutic trials. Neurotherapeutics 19:8\u201325. https:\/\/doi.org\/10.1007\/s13311-022-01185-z","journal-title":"Neurotherapeutics"},{"key":"2006_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpsychires.2020.07.015","volume":"129","author":"LH Chen","year":"2020","unstructured":"Chen LH, Heng Mak TS, Fan Y et al (2020) Associations between CLU polymorphisms and memory performance: the role of serum lipids in Alzheimer\u2019s disease. J Psychiatr Res 129:281\u2013288. https:\/\/doi.org\/10.1016\/j.jpsychires.2020.07.015","journal-title":"J Psychiatr Res"},{"key":"2006_CR33","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1523\/JNEUROSCI.5794-10.2011","volume":"31","author":"MN Braskie","year":"2011","unstructured":"Braskie MN, Jahanshad N, Stein JL et al (2011) Common Alzheimer\u2019s disease risk variant within the CLU gene affects white matter microstructure in young adults. J Neurosci 31:6764. https:\/\/doi.org\/10.1523\/JNEUROSCI.5794-10.2011","journal-title":"J Neurosci"},{"key":"2006_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033923","volume":"7","author":"I-F Ling","year":"2012","unstructured":"Ling I-F, Bhongsatiern J, Simpson JF et al (2012) Genetics of clusterin isoform expression and Alzheimer\u2019s disease risk. PLoS ONE 7:e33923. https:\/\/doi.org\/10.1371\/journal.pone.0033923","journal-title":"PLoS ONE"},{"key":"2006_CR35","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1523\/JNEUROSCI.5236-13.2014","volume":"34","author":"FF Roussotte","year":"2014","unstructured":"Roussotte FF, Gutman BA, Madsen SK et al (2014) Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly. J Neurosci 34:6537\u20136545. https:\/\/doi.org\/10.1523\/JNEUROSCI.5236-13.2014","journal-title":"J Neurosci"},{"key":"2006_CR36","doi-asserted-by":"publisher","first-page":"26027","DOI":"10.1038\/srep26027","volume":"6","author":"L Tan","year":"2016","unstructured":"Tan L, Wang H-F, Tan M-S et al (2016) Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer\u2019s disease cohorts. Sci Rep 6:26027. https:\/\/doi.org\/10.1038\/srep26027","journal-title":"Sci Rep"},{"key":"2006_CR37","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.kint.2021.10.018","volume":"101","author":"V Jankowski","year":"2022","unstructured":"Jankowski V, Saritas T, Kjolby M et al (2022) Carbamylated sortilin associates with cardiovascular calcification in patients with chronic kidney disease. Kidney Int 101:574\u2013584. https:\/\/doi.org\/10.1016\/j.kint.2021.10.018","journal-title":"Kidney Int"},{"key":"2006_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH et al (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39:168\u2013177. https:\/\/doi.org\/10.1038\/ng1943","journal-title":"Nat Genet"},{"key":"2006_CR39","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/J.NEUROBIOLAGING.2007.10.013","volume":"30","author":"EK Tan","year":"2009","unstructured":"Tan EK, Lee J, Chen CP et al (2009) SORL1 haplotypes modulate risk of Alzheimer\u2019s disease in Chinese. Neurobiol Aging 30:1048\u20131051. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2007.10.013","journal-title":"Neurobiol Aging"},{"key":"2006_CR40","first-page":"593","volume":"51","author":"PT M\u00e4nnist\u00f6","year":"1999","unstructured":"M\u00e4nnist\u00f6 PT, Kaakkola S (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593\u2013628","journal-title":"Pharmacol Rev"},{"key":"2006_CR41","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1681\/ASN.2008080915","volume":"20","author":"A Haase-Fielitz","year":"2009","unstructured":"Haase-Fielitz A, Haase M, Bellomo R et al (2009) Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol 20:1393\u20131403. https:\/\/doi.org\/10.1681\/ASN.2008080915","journal-title":"J Am Soc Nephrol"},{"key":"2006_CR42","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1021\/bi00013a008","volume":"34","author":"T Lotta","year":"1995","unstructured":"Lotta T, Vidgren J, Tilgmann C et al (1995) Kinetics of human soluble and membrane-bound catechol o-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202\u20134210. https:\/\/doi.org\/10.1021\/bi00013a008","journal-title":"Biochemistry"},{"key":"2006_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-4-64","author":"TT Rakv\u00e5g","year":"2008","unstructured":"Rakv\u00e5g TT, Ross JR, Sato H et al (2008) Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol Pain. https:\/\/doi.org\/10.1186\/1744-8069-4-64","journal-title":"Mol Pain"},{"key":"2006_CR44","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.1073\/pnas.111134598","volume":"98","author":"MF Egan","year":"2001","unstructured":"Egan MF, Goldberg TE, Kolachana BS et al (2001) Effect of COMT Val108\/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci 98:6917\u20136922. https:\/\/doi.org\/10.1073\/pnas.111134598","journal-title":"Proc Natl Acad Sci"},{"key":"2006_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00363","author":"M Miranda","year":"2019","unstructured":"Miranda M, Morici JF, Zanoni MB, Bekinschtein P (2019) Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2019.00363","journal-title":"Front Cell Neurosci"},{"key":"2006_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0004563214533514","volume":"52","author":"M Marchelek-My\u015bliwiec","year":"2015","unstructured":"Marchelek-My\u015bliwiec M, Cichocka E, Dziedziejko V et al (2015) Insulin resistance and brain-derived neurotrophic factor levels in chronic kidney disease. Ann Clin Biochem 52:213\u2013219. https:\/\/doi.org\/10.1177\/0004563214533514","journal-title":"Ann Clin Biochem"},{"key":"2006_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13098-023-00991-5","volume":"15","author":"C-Y Hsu","year":"2023","unstructured":"Hsu C-Y, Sheu WH-H, Lee I-T (2023) Brain-derived neurotrophic factor associated with kidney function. Diabetol Metab Syndr 15:16. https:\/\/doi.org\/10.1186\/s13098-023-00991-5","journal-title":"Diabetol Metab Syndr"},{"key":"2006_CR48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","volume":"112","author":"MF Egan","year":"2003","unstructured":"Egan MF, Kojima M, Callicott JH et al (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257\u2013269. https:\/\/doi.org\/10.1016\/S0092-8674(03)00035-7","journal-title":"Cell"},{"key":"2006_CR49","doi-asserted-by":"publisher","first-page":"10099","DOI":"10.1523\/JNEUROSCI.2680-04.2004","volume":"24","author":"L Pezawas","year":"2004","unstructured":"Pezawas L, Verchinski BA, Mattay VS et al (2004) The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24:10099\u201310102. https:\/\/doi.org\/10.1523\/JNEUROSCI.2680-04.2004","journal-title":"J Neurosci"},{"key":"2006_CR50","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/mp.2014.123","volume":"20","author":"YY Lim","year":"2015","unstructured":"Lim YY, Villemagne VL, Laws SM et al (2015) APOE and BDNF polymorphisms moderate amyloid \u03b2-related cognitive decline in preclinical Alzheimer\u2019s disease. Mol Psychiatry 20:1322\u20131328. https:\/\/doi.org\/10.1038\/mp.2014.123","journal-title":"Mol Psychiatry"},{"key":"2006_CR51","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10157-022-02268-z","volume":"26","author":"B Afsar","year":"2022","unstructured":"Afsar B, Afsar RE (2022) Brain-derived neurotrophic factor (BDNF): a multifaceted marker in chronic kidney disease. Clin Exp Nephrol 26:1149\u20131159. https:\/\/doi.org\/10.1007\/s10157-022-02268-z","journal-title":"Clin Exp Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02006-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02006-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02006-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:10Z","timestamp":1777564390000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/9\/2473\/8306170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2006"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02006-6","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,6]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable: Reviews do not require ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable: reviews do not deal with individual patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}